secwatch.observer — SEC 8-K summary
======================================

Issuer:     ELUTIA INC. (ELUT)
CIK:        0001708527
Form:       8-K
Filed at:   2023-09-21T23:59:59+00:00
Accession:  0001104659-23-102812
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Elutia raises $10.5M in PIPE with up to $26.2M from warrants; plus divestiture >$60M total cash
--------------------------------------------------------------------------------

- Initial gross proceeds ~$10.5M from sale of 7.36M shares/pre-funded warrants and 11.03M common warrants.
- Full exercise of warrants would add $15.8M, bringing total PIPE proceeds to $26.2M.
- Combined with Orthobiologics divestiture (announced Sep 18), total cash added >$60M.
- Warrants exercisable at $1.4275 until 30 trading days post-FDA clearance of CanGarooRM or 5 years.
- Investors include existing HighCape Capital, new Nantahala Capital, and a life-sciences fund.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1708527/000110465923102812/0001104659-23-102812-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1708527/000110465923102812/tm2326577d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-102812

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer